Based on Glut1 and CAIX expression in tumour and stroma of tissue samples from 132 breast cancer patients, TNBC was metabolically divided into Warburg type (most common, 59.8%), reverse Warburg type (least common, 5.3%), mixed metabolic type (18.2%), and metabolic null type (16.7%) [35]. This evidence concerns the gene SLC2A1 and breast cancer.